Related Experiment Videos

Bacterial polysaccharide-protein conjugate vaccines

Adam Finn1

  • 1Institute of Child Health, Level 6, UBHT Education Centre, Upper Maudlin Street, Bristol BS2 8AE, UK. adam.finn@bristol.ac.uk

British Medical Bulletin
|September 2, 2004
PubMed
Summary

Polysaccharide-protein conjugate vaccines, initially developed in the 1920s, are crucial for preventing bacterial infections like Haemophilus influenzae type b. Their resurgence in the late 20th century combats antibiotic resistance and reshapes childhood infection epidemiology.

Related Concept Videos